Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

CEO

Dr. Michael Jeffrey Sinclair

Employees

174

Country

United Kingdom

ISIN

GB00BD6SX109

WKN

000A2AL9X

Listings

STU

R3I1.STU

0 Comments

Share your thoughts

FAQs

What is Advanced Oncotherapy stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Advanced Oncotherapy stocks are traded under the ticker R3I1.STU.

How many employees does Advanced Oncotherapy have?▼

As of November 3, 2026, the company has 174 employees.

In which sector is Advanced Oncotherapy located?▼

Advanced Oncotherapy operates in the Health & Wellness sector.

When did Advanced Oncotherapy complete a stock split?▼

Advanced Oncotherapy has not had any recent stock splits.

Where is Advanced Oncotherapy headquartered?▼

Advanced Oncotherapy is headquartered in London, United Kingdom.